Product information and disease descriptionProduct descriptionProduct information
American hospital formulary service (AHFS), or other drug classification
4 evidence topics · 4 sources
Pharmacologic class stated by the manufacturer
Proposed International Nonproprietary Name and class description
| Field | Quoted record |
|---|---|
| Proposed INN (Latin) | “envudeucitinibum” |
| Class description | “Janus kinase inhibitor, anti-inflammatory” |
| Class description (French) | “inhibiteur de la kinase de Janus, anti-inflammatoire” |
Nonproprietary name stem -citinib
Nomenclature and drug dictionary entries in the FDA substance registration record
| Field | Quoted record |
|---|---|
| Substance type | “INGREDIENT SUBSTANCE” |
| Molecular formula | “C22H24N6O3” |
| United States Adopted Name synonym | “ENVUDEUCITINIB [USAN]” |
| WHO Drug Dictionary synonym | “ESK 001 [WHO-DD]” |